Navigation Links
Moores UCSD Cancer Center Luau and Longboard Invitational Hosts Survivor Beach Aug. 9
Date:7/10/2009

LA JOLLA, Calif., July 10 /PRNewswire/ -- Surfers, cancer survivors and supporters will gather on Sunday, August 9 on the shore of the Pacific Ocean with a special purpose: to show their support for the fight against cancer. As participants in the third annual Survivor Beach, they will place their surfboards in the sand, one-by-one, nose-to-tail, with the goal of forming the world's longest line of surfboards. The line will start at Scripps Pier and continue down La Jolla Shores beach. Survivor Beach was established in 2007 to bring members of the community together to create a symbol of support for cancer research and for the survivors and others who have been affected by the disease. The event will take place from 8-11 a.m. and is hosted by the Moores UCSD Cancer Center as a precursor to its 16th annual Luau and Longboard Invitational.

"Survivor Beach is a powerful symbol of the community's commitment to supporting the quest for a cure for cancer," said Dennis Carson, MD, director of the Moores UCSD Cancer Center.

Last year, more than 200 people joined the event to create a line of record length. "Since the founding of Survivor Beach, we have seen a tremendous response," said Jessica Yingling, this year's co-chair of the Luau and Longboard Invitational. "The impressive turnout is a testament to the community's deep support for cancer research and willingness to join in making a stand in the fight against cancer."

According to the American Cancer Society, advancements in early detection and new treatments over the past decade have reduced the annual number of deaths from cancer by 16 percent. However, cancer remains the second leading cause of death in the United States and one in three will have cancer at some point in their lives. That is why it is important to continue to support further research into the disease, prevention and potential treatments.

Sponsored by Genentech Oceanside, Survivor Beach is free and open to the public. Participants will receive a free souvenir and will be registered to win a pair of tickets to the 16th annual Moores UCSD Cancer Center Luau & Longboard Invitational. The person who brings the most surfboards will receive a prize. Registration starts at 8:00 a.m., August 9 on the beach by Scripps Pier. For more information and directions, please visit http://www.longboardluau.org/survivorbeach.html.

Survivor Beach precedes the annual Luau & Longboard Invitational, which will be held on August 23 and will celebrate 16 years surfing for a cure. Since its founding, the "Longboard Luau" has raised more than $3 million to fund groundbreaking cancer research at the Moores UCSD Cancer Center, the region's only comprehensive cancer center designated by the National Cancer Institute. For more information about sponsorship opportunities, team entries and tickets for the Luau and Longboard Invitational, contact the Moores UCSD Cancer Center at (858) 822-0023 or visit http://www.longboardluau.org.

Giving to Moores UCSD Cancer Center

The Moores UCSD Cancer Center is dedicated to translating promising scientific discoveries into new and better options for the care of patients with cancer. Founded in 1979, it is the only center in San Diego and Imperial counties to hold a National Cancer Center Institute designation as a Comprehensive Cancer Center, and is one of just 41 such centers in the United States. As such, it ranks among the top centers in the nation conducting basic and clinical cancer research, providing advanced patient care, and serving the community through outreach and education programs. The Moores UCSD Cancer Center must increasingly rely on financial support from private sources to pursue groundbreaking research and innovative programs. Your generous support helps its physicians and scientists find ways to defeat cancer and continue to provide the most compassionate care possible to patients and families. For more information, please call 858-822-0175 or visit www.cancer.ucsd.edu.

About Genentech

Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a wholly-owned member of the Roche Group, has headquarters in South San Francisco, California and a manufacturing and clinical operations facility in Oceanside, California. For additional information about the company, please visit http://www.gene.com.


'/>"/>
SOURCE Moores UCSD Cancer Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Zounds Hearing Enters Moorestown and Announces $225,000 Hearing Partnership With Twilight Wish Foundation
2. Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center
3. Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients
4. Moores UCSD Cancer Center Luau and Longboard Invitational Announce Dr. David Easter to Receive the 2009 Rell Sunn Queen of Makaha Award
5. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
6. Survival differences by race most apparent in advanced stages of breast cancer
7. MRI finds breast cancer before it becomes dangerous
8. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
9. Pathway links inflammation, angiogenesis and breast cancer
10. Radiologists encouraged to look beyond cancer for clinically unseen diseases
11. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Usually, the impending arrival of warmer weather means the gleeful banishment of ... chin, this means more anxiety than elation. The cosmetic dermatology experts at Cosmetic Laser ... chin is undesirable,” Dr. Goldman said, “but it seems doubly so when the fat ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... release of two biometric time and attendance tracking products: the new NCheck Cloud ... NCheck Cloud Bio Attendance uses biometric face recognition to enable users to check ...
(Date:3/28/2017)... ... ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio and New ... sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National Advisory Board., ... the clinic from a small start-up to number 78 in the country based on ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice ... Atlantic City March 13-16, was a busy spot this year. Liz Solovay and ... strategies for preventing outbreaks among camp communities during the upcoming 2017 camping season. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Nurse practitioners ... as their value increases in the healthcare workforce, according to a survey recently ... boards, career fairs, and candidate leads to healthcare employers of physicians and advanced ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Israel , March 28, 2017 Emosis ... This new business entity, Emosis Ltd, headquartered in Tel ... of novel assays complementing the mother company existing technology platform and ... and sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. ...
(Date:3/28/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a ... commercialization of innovative therapies for the treatment of ... Agency (EMA) has notified the company that the ... Application (MAA) has passed validation, and that the ... MAA for ARX-04 (known as DSUVIA™ in the ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: